Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Rosuvastatin 20-mg/5-mL Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Page(s):  152

Note:  Electronic version includes errata or revisions.

Rosuvastatin 20-mg/5-mL Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Rosuvastatin 20-mg/5-mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist. NOTE: This formulation replaces the original Rosuvastatin 20 mg/mL Oral Suspension formula due to corrections made to original sources. Please see note under references for further information.

Related Keywords: rosuvastatin, formulation, statin drug, hyperlipidemia, high cholesterol, antihyperlipidemic agent, lipid disorders

Related Categories: FORMULATIONS, CARDIOLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Rosuvastatin 20-mg/5-mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 152

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Atorvastatin 10-mg or 20-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 232

Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 420

Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
Mar/Apr 2010
Pg. 151

Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2011
Pg. 506

Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
Jul/Aug 2018
Pg. 294-300

Amoxicillin 125-mg/5-mL and 250-mg/5-mL Suspensions
Allen Loyd V Jr
Jan/Feb 2003
Pg. 55

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
May/Jun 2018
Pg. 220-228

Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 239

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 233

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Acyclovir 20-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2013
Pg. 326

Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 243

Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
Jul/Aug 2011
Pg. 302-307

Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 340

Return to Top